Charles G. Mullighan
0000-0002-1871-1850
Publication & Citation Trends
Publications
0 total
Uncovering the genomic complexity of PAX5 intragenic tandem multiplication via long-read and short-read sequencing.
Cited by 0
Semantic Scholar
IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response
Cited by 0
Semantic Scholar
Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.
Cited by 0
Semantic Scholar
CRLF2-rearrangement and Extramedullary Disease in B-cell Acute Lymphoblastic Leukemia: A Possible Link?
Cited by 0
Semantic Scholar
Correction: Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia.
Cited by 0
Semantic Scholar
DHODH as a Targetable Metabolic Achilles' Heel for chemo-resistant B-ALL.
Cited by 0
Semantic Scholar
Abstract 7237: LDB1-dependent enhancer connectivity constrains a metabolic synthetic lethality in T-cell acute lymphoblastic leukemia
Cited by 0
Semantic Scholar
Long-read whole-transcriptome sequencing and selective gene panel profiling enable sensitive detection of fusion oncogenes in pediatric B-cell acute lymphoblastic leukemia.
Cited by 0
Semantic Scholar
Research Topics
Acute Lymphoblastic Leukemia research
(649)
Acute Myeloid Leukemia Research
(337)
Chronic Myeloid Leukemia Treatments
(234)
Chronic Lymphocytic Leukemia Research
(142)
Cancer Genomics and Diagnostics
(137)
Affiliations
South Australia Pathology
University of Vermont
University of Bern
Fox Chase Cancer Center
National Institutes of Health